Involved-field radiotherapy alone for early-stage non-small-cell lung cancer (Q34054127)

30 July 2017

1 reference

title

Involved-field radiotherapy alone for early-stage non-small-cell lung cancer (English)

1 reference

30 July 2017

0 references

1 reference

Cheung PC

1

1 reference

30 July 2017

Mackillop WJ

2

1 reference

30 July 2017

Dixon P

3

1 reference

30 July 2017

Brundage MD

4

1 reference

30 July 2017

Youssef YM

5

1 reference

30 July 2017

Zhou S

6

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

International Journal of Radiation Oncology Biology Physics

30 July 2017

1 reference

30 July 2017

48

1 reference

30 July 2017

3

1 reference

30 July 2017

703-710

1 reference

The National Cancer Data Base report on lung cancer

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Can lung cancer be cured by irradiation alone?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Medically Inoperable Lung Carcinoma: The Role of Radiation Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

The role of curative radiotherapy in the treatment of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Local control in medically inoperable lung cancer: an analysis of its importance in outcome and factors determining the probability of tumor eradication

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

The Curative Treatment by Radiotherapy Alone of Stage I Non-Small Cell Carcinoma of the Lung

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Radical radiotherapy for early nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Radiation therapy alone for stage I non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Curative radiotherapy for technically operable stage I nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Clinical stage II non-small cell lung cancer treated with radiation therapy alone. The significance of clinically staged ipsilateral hilar adenopathy (N1 disease)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Clinical implication of symptoms in patients with non-small cell lung cancer treated with definitive radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Curative radiotherapy of early operable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Radiotherapy alone for patients with operable carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Hyperfractionated radiotherapy for clinical stage II non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Curative radiotherapy in non-small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost for the treatment of nonsmall cell lung cancer: unusual toxicity and promising early results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

The linear-quadratic formula and progress in fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

Actual growth rate and tumour cell proliferation in human pulmonary neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900667-2

7 January 2021

10.1016/S0360-3016(00)00667-2

Identifiers

DOI

1 reference

30 July 2017

1 reference